Εκπαιδευτικά προγράμματα

Καταχωρήθηκε: Κυριακή 26 Φεβ 2017
We discussed possibilities to enhance immune reconsitution after transplnatation. A review apper was presented. Besides pre-HCT and inter HCT measures we aslso discussed the interventions that can be done after transplantation, especailly cellular therapy (CTLs). The available pharmacological measures with IL-2 and sex steroid abaltio...
Καταχωρήθηκε: Σάββατο 25 Φεβ 2017
 we discusssed how to select the best haploidentical donor in T-cell replete Haploidentical Transplantation. The algorithm was implemented in our policy.  Presenter: Spyridonidis Participants: all medical staff
Καταχωρήθηκε: Πέμπτη 23 Φεβ 2017
We presented the papers/debate  regarding which is the better donor (VUD or haplo) published in Blood Advances. Presenter: A. Spyridonidis Participants: All medical staff.     Related haploidentical donors are a better choice than matched unrelated donors: Counterpoi"Related haploidentical donors are a better choice than matched unrelateddonors: Counterpoint" by Bronwen E....
Καταχωρήθηκε: Τρίτη 14 Φεβ 2017
We ahve been informed about the subcutan administration of immunoglobulins with the use of hyalorunidase. This troute of administration is attractive for our patients who have difficult venous access. Conceerns are possible infections at the site of injection, something which we will evaluate. Presenter: Medical...
Καταχωρήθηκε: Τρίτη 31 Ιαν 2017
Στα πλαίσια του εκπαιδευτικού προγράμματος της ΜΜΜΟ, την Τρίτη 31/1/17 δόθηκε διάλεξη από την κα Κυριάκου της Δερματολογικής κλινικής του ΠΓΝΠ με θέμα : Διάγνωση δερματικού GVHD από τη πλευρά του δερματολόγου. Η διάλεξη πραγματοποιήθηκε στο γραφείο ιατρών της ΜΜΜΟ, στις 13:00 Παρόντες¨όλο το ιατρικό προσωπικό
Καταχωρήθηκε: Σάββατο 28 Ιαν 2017
Keypoints that discussed: prevalance at out Hospital, sources of infection, prophylactic measures.  Risk-adapted strategy according to identifying those patients at higher risk for MDR GNB infectiona dn previous history of colonization. The value of surveillance studies. How to approach MDR GNB infections in neutropenic patients? We adapted...
Καταχωρήθηκε: Παρασκευή 27 Ιαν 2017
Diagnosis and treatment of BO after trasnplantation is a major challenge. Distinguish between BO and BOOP (new terminology COP-cryptogenic organizing pneumonia) is of clinicaql importance because f the differetent therpauetic approach. The importnace of lung function testst and correct interpretation was discussed and will be...
Καταχωρήθηκε: Παρασκευή 27 Ιαν 2017
We discussed the recent publication in Blood regarding current guideliens in the managment of AML. These guideliens are imp;lementedd in our policy. Reagrding flt3ITD + AML we aim to participate in a multicenter study with the prophylactic use of a new inhibitor after trasnplantation. Lecturer:...
Καταχωρήθηκε: Δευτέρα 23 Ιαν 2017
Clinical case: a patient has only mismatched donors. Whioch one should we choose. We discussed these issues of HLA matching, GvH and HvG diirection, the importance of differtent HLA mismatches,  premissive mismatches vs low expression alleles. Three sceanrios were discussed in detail Lecturer: Prof. Spyridonidis Participants: all...
Καταχωρήθηκε: Κυριακή 22 Ιαν 2017
Clinical case: PAtient wilt ALL seeks consulation for transplant or not. What is the value of MRD diagnostic? How do we perform MRD diagnostic Discussion: We discussed the challenges of MRD. The new nomenclature names MRD not minimal residula disease but measurable residual disease. Howerver...
Καταχωρήθηκε: Κυριακή 22 Ιαν 2017
During the last years we used different sytems to evaluate and grade chronic GvHD, which were implenmeted in our Unit. Starting form the classical limited/extensive categorization, we used the last years the NIH mild/severe/moderate classification. We dicussed a nce review form Lee regarding cGvHD...
Καταχωρήθηκε: Κυριακή 22 Ιαν 2017
Our previous evaluation, publisehd in BMT revealed the higher GvHD and TRM in mismatched PBSCT. We discussed our prospective study adding either MMF or 1 day post-Cy in our current 20mg Camoth anti GvHD practice.We also discussed the paper "Prospective study of nonmyeloablative, HLA-mismatched...
Καταχωρήθηκε: Κυριακή 22 Ιαν 2017
We discussed the QM sytem in our BMT Unit. Points that were discussed: SOP, Policies, Forms, document managment system, Corrective actions, deviations. Master files in the process from referal of a patient to transplantation and than follow up. Lecturer: Spyridonidis Participants: medical and administrative staff  
Καταχωρήθηκε: Κυριακή 22 Ιαν 2017
Clinical Case in our Unit: PAtient with relapsed Hodgkin with intial mediastinal involvement, now after autologous PBSCT: Should we perform consolidated radiotherapy Disucssed: the value of radiotherapy in Hodgkin, current guideleines lecturer: Prof KArdamakis, Head of the Radiotherapy dept, University of Patras Participants: all medical staff 
Καταχωρήθηκε: Κυριακή 22 Ιαν 2017
Clinical case in our Unit: ADV lung infection We discussed the diagnostic challenges of ADV infection and the antiviral treatment in immunocomprimised patients. Other sites of manifestation besides lung (CNS?). The value of stool diagnostics. Lecturer: M Marangos Participants: all medical staff
Καταχωρήθηκε: Δευτέρα 12 Δεκ 2016
Bone Marrow Transplantation (2012) 47, 1499 -- 1506
Καταχωρήθηκε: Κυριακή 11 Δεκ 2016
Καταχωρήθηκε: Κυριακή 11 Δεκ 2016
From Renal Complications of Hematopoietic-Cell Transplantation Sangeeta Hingorani, M.D., M.P.H. N Engl J Med 2016; 374:2256-2267June 9, 2016DOI: 10.1056/NEJMra1404711  
Καταχωρήθηκε: Κυριακή 11 Δεκ 2016
N Engl J Med 2014;371:1507-17.
Βρέθηκαν 274 αποτελέσματα. Σελίδα 11 από 14
Σελίδα << < [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] >


Τηλέφωνα Επικοινωνίας:


Γραμματεία MMMO: 2613 603506 (ασθενείς), 2613 604062 (Γραμματεία Διευθυντή) 
Fax : 2613 604066,
email (για ιατρούς): transplant@upatras.gr,
email (για ασθενείς): mmak@upatras.gr
email (για θέματα κλινικών μελετών) : gcppatras@gmail.com
Μονάδα Μεταμόσχευσης (Νοσηλεία): 2613 603 261
Γραφείο Ιατρών: 2613 604064, 2613 604065,
Εφημερεύων Ιατρός: 2610 999111 (τηλ. κέντρο ΠΓΝΠ)


βρείτε μας στο χάρτη


Login / Sitemap


© Copyright 2015 - 2021 Μονάδα Μεταμόσχευσης Μυελού των Οστών Πάτρας